“Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection”
by Austen Terwilliger, Justin Clark, Maile Karris, Haroldo Hernandez-Santos, Sabrina Green, Saima Aslam and Anthony Maresso
Viruses 2021, 13(10), 2049; https://doi.org/10.3390/v13102049
Available online: https://www.mdpi.com/1999-4915/13/10/2049

“Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation”
by Kevin Paul, Maya Merabishvili, Ronen Hazan, Martin Christner, Uta Herden, Daniel Gelman, Leron Khalifa, Ortal Yerushalmy, Shunit Coppenhagen-Glazer, Theresa Harbauer et al.
Viruses 2021, 13(9), 1785; https://doi.org/10.3390/v13091785
Available online: https://www.mdpi.com/1999-4915/13/9/1785

“The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies”
by Dan Liu, Jonas D. Van Belleghem, Christiaan R. de Vries, Elizabeth Burgener, Qingquan Chen, Robert Manasherob, Jenny R. Aronson, Derek F. Amanatullah, Pranita D. Tamma and Gina A. Suh
Viruses 2021, 13(7), 1268; https://doi.org/10.3390/v13071268
Available online: https://www.mdpi.com/1999-4915/13/7/1268

“A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient”
by David Lebeaux, Maia Merabishvili, Eric Caudron, Damien Lannoy, Leen Van Simaey, Hans Duyvejonck, Romain Guillemain, Caroline Thumerelle, Isabelle Podglajen, Fabrice Compain et al.
Viruses 2021, 13(1), 60; https://doi.org/10.3390/v13010060
Available online: https://www.mdpi.com/1999-4915/13/1/60

“A Design of Experiment Approach to Optimize Spray-Dried Powders Containing Pseudomonas aeruginosaPodoviridae and Myoviridae Bacteriophages”
by Emilie Tabare, Tea Glonti, Christel Cochez, Cyrille Ngassam, Jean-Paul Pirnay, Karim Amighi and Jonathan Goole
Viruses 2021, 13(10), 1926; https://doi.org/10.3390/v13101926
Available online: https://www.mdpi.com/1999-4915/13/10/1926

“Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic Escherichia coli”
by Lívia Slobodníková, Barbora Markusková, Michal Kajsík, Michal Andrezál, Marek Straka, Adriána Liptáková and Hana Drahovská
Viruses 2021, 13(7), 1348; https://doi.org/10.3390/v13071348
Available online: https://www.mdpi.com/1999-4915/13/7/1348

“Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection”
by Tristan Ferry, Camille Kolenda, Thomas Briot, Aubin Souche, Sébastien Lustig, Jérôme Josse, Cécile Batailler, Fabrice Pirot, Mathieu Medina, Gilles Leboucher et al.
Viruses 2021, 13(12), 2414; https://doi.org/10.3390/v13122414
Available online: https://www.mdpi.com/1999-4915/13/12/2414

“Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence”
by Elisabed Zaldastanishvili, Lika Leshkasheli, Mariam Dadiani, Lia Nadareishvili, Lia Askilashvili, Nino Kvatadze, Marina Goderdzishvili, Mzia Kutateladze and Nana Balarjishvili
Viruses 2021, 13(10), 1901; https://doi.org/10.3390/v13101901
Available online: https://www.mdpi.com/1999-4915/13/10/1901

“A Case of In Situ Phage Therapy against Staphylococcus aureus in a Bone Allograft Polymicrobial Biofilm Infection: Outcomes and Phage-Antibiotic Interactions”
by Brieuc Van Nieuwenhuyse, Christine Galant, Bénédicte Brichard, Pierre-Louis Docquier, Sarah Djebara, Jean-Paul Pirnay, Dimitri Van der Linden, Maya Merabishvili and Olga Chatzis
Viruses 2021, 13(10), 1898; https://doi.org/10.3390/v13101898
Available online: https://www.mdpi.com/1999-4915/13/10/1898

“Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)”
by Jolien Onsea, Saartje Uyttebroek, Baixing Chen, Jeroen Wagemans, Cédric Lood, Laura Van Gerven, Isabel Spriet, David Devolder, Yves Debaveye, Melissa Depypere et al.
Viruses 2021, 13(8), 1543; https://doi.org/10.3390/v13081543
Available online: https://www.mdpi.com/1999-4915/13/8/1543